Alternatives to Nanordica Medical

Developing wearable brain imaging systems using quantum sensing technology.

A clinical-stage dermatology company developing novel therapies for inflammatory skin diseases.

Redefining kidney stone treatment with an aspiration-based stone removal system.

Pioneering neuro-endovascular surgical robotics for precise, remote-controlled treatment of brain aneurysms and strokes.

Revolutionizing the treatment of thromboembolic disease through innovative medical technology and connected care solutions.

Developing a minimally invasive, one-time outpatient therapy for obesity treatment.

A medical device company offering a comprehensive, swallowable gastric balloon program for weight loss.

Developing innovative, minimally invasive solutions for tricuspid valve disease treatment.

A global medical technology company focused on women's health and wellness, particularly in breast aesthetics and reconstruction.

Developing innovative ophthalmic devices for refractive surgery, specifically the Gemini Refractive Capsule for cataract surgery.

Developing neurotomy solutions for chronic rhinitis.

Developing innovative intravascular lithotripsy technology for treating calcified peripheral artery disease.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

AI-powered breast cancer detection and risk assessment solutions.

Developing ultrasound-mediated nonviral genetic medicines.

Pioneering vision restoration therapies for severe retinal degenerations.

Developing novel male contraceptives.

Global leader in enzymatic therapeutics for non-surgical tissue repair, replacing existing standards of care.

Develops and distributes bioreactor technology for stem cell cultivation.

Global musculoskeletal solutions company developing implants, robotics, and enabling technologies for spine and orthopedic procedures.

Developing a new histotripsy therapeutic platform for cancer treatment.

Develops and supplies cloud-connectable medical devices and software for respiratory conditions.

Elevating uterine health through innovative biomaterial therapies.

Developing a novel neurostimulator for the treatment of obstructive sleep apnea.

Develops multimodal hemoadsorption therapeutic devices for sepsis and septic shock.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Developing ultra-high bandwidth brain-machine interfaces to connect humans and computers.

Dopl Technologies is a medical technology company developing a robotic ultrasound platform to expand access to diagnostic imaging in underserved communities.

Developing innovative medical devices for cardiovascular interventions.

Digital pathology imaging technology and AI-driven precision pathology software.

Developer of innovative, controllable neurovascular devices for the treatment of ischemic and hemorrhagic stroke.

AI safety and research company building reliable, interpretable, and steerable AI systems.

Robotic surgery technology designed to expand access to minimally invasive procedures.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

Pioneer in Smart Sleep Medicine, offering non-CPAP alternatives for Obstructive Sleep Apnea.

AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.

Medical technology company developing bio-integrative, metal-free orthopedic fixation implants for natural bone healing.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Global CRDMO providing integrated R&D and manufacturing services for the pharmaceutical and life sciences industries.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

AI-guided drug discovery platform for tissue-targeted medicines.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

AI-powered research assistant for scientific literature review and data extraction.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Developer of minimally invasive thermal water vapor therapy for treating benign prostatic hyperplasia (BPH).

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Global supplier of life science research tools, including antibodies, reagents, and assays.

Developer of proprietary shape memory polymer technology for endovascular embolization.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Quantum software company enabling breakthroughs in chemistry, materials science, and life sciences.

A vertically-integrated procurement platform for the life sciences industry.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.